{"disease":{"id":"elevated-lipoprotein-a-level","name":"elevated lipoprotein a level"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06014060","title":"24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":3300,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}